全球智慧吸入器市場規模、佔有率、成長分析、依類型（乾粉吸入器和計量吸入器）、依配銷通路、依最終用途 - 2024-2031 年行業預測

2022年全球智慧吸入器市場規模為122.2億美元，預計將從2023年的146.4億美元成長到2031年的621.1億美元，在預測期內（2024-2031年）複合年成長率為19.8%。

快速擴張的全球智慧吸入器市場（醫療保健領域的一個部門）正在徹底改變包括氣喘和慢性阻塞性肺病在內的呼吸系統疾病的治療。智慧吸入器是一種使用感測器和藍牙技術追蹤和監控患者吸入器使用的醫療設備。醫療保健專業人員可以使用智慧吸入器收集的資料來更好地監測患者對處方時間表的遵守情況，並根據需要修改治療策略。透過允許醫療保健從業人員監測患者藥物使用情況並即時調整治療計劃，該行業旨在提高呼吸系統疾病治療的功效和效率。

目錄

執行摘要

• 市場概況
• 命運之輪

研究方法論

• 資訊採購
• 二手和主要資料來源
• 市場規模估計
• 市場假設與限制

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題

主要市場洞察

• 技術分析
• 定價分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 貿易分析
• 啟動分析
• 原料分析
• 創新矩陣
• 管道產品分析
• 總體經濟指標
• 頂級投資分析
• 成功的關鍵因素
• 競爭程度

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 限制
  • 課題
• 監管環境
• 波特分析
• 對未來顛覆的特別見解

依類型分類的全球智慧吸入器市場

• 市場概況
• 乾粉吸入器 (DPI) 和定量吸入器 (MDI)

依配銷通路分類的全球智慧吸入器市場

• 市場概況
• 醫院藥房
• 零售藥局
• 網路藥局

全球智慧吸入器市場（依最終用途）

• 市場概況
• 醫院
• 家庭護理設置
• 和別的

全球智慧吸入器市場規模（依地區）

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • MEA 的其餘部分

競爭格局

• 前 5 名企業比較
• 2021 年關鍵參與者的市場定位
• 主要市場參與者所採取的策略
• 最佳制勝策略
• 近期市集活動
• 主要公司市佔率（%），2021年

主要公司簡介

• Teva Pharmaceuticals (Israel)
• GlaxoSmithKline (UK)
• Novartis (Switzerland)
• AstraZeneca (UK)
• Boehringer Ingelheim (Germany)
• Philips Respironics (US)
• Propeller Health (US)
• Vectura Group (UK)
• Opko Health (US)
• Adherium Limited (New Zealand)
• AptarGroup (US)
• Cohero Health (US)
• H&T Presspart (UK)
• 3M Company (US)
• Cipla (India)
• Mundipharma (UK)
• Glenmark Pharmaceuticals (India)
• Chiesi Farmaceutici (Italy)
• Propeller Health (US)
• Sensirion AG (Switzerland)

Global Smart Inhalers Market size was valued at USD 12.22 billion in 2022 and is poised to grow from USD 14.64 billion in 2023 to USD 62.11 billion by 2031, growing at a CAGR of 19.8% during the forecast period (2024-2031).

The treatment of respiratory conditions including asthma and COPD is being revolutionized by the quickly expanding global smart inhalers market, a sector of the healthcare sector. Smart inhalers are medical devices that track and monitor patients' inhaler usage using sensors and Bluetooth technology. Healthcare professionals can use the data that smart inhalers collect to better monitor patient adherence to prescription schedules and modify treatment strategies as necessary. By allowing healthcare practitioners to monitor patient drug usage and make real-time treatment plan adjustments, the industry aims to improve the efficacy and efficiency of respiratory disease therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Inhalers Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Inhalers Market Segmental Analysis

Global Smart Inhalers Market is segmented on the basis of type, distribution channel, end-use, and region. By type, the market is segmented into dry powdered inhalers (DPIs) and metered dose inhalers (MDIs). By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. By end-use, the market is segmented into hospitals, homecare settings, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Smart Inhalers Market

Innovations in technology are a major factor propelling the market for smart inhalers. The treatment of respiratory disorders has changed dramatically as a result of the introduction of sophisticated sensors, networking choices, and data analytics tools. Personalized treatment and better patient outcomes are made possible by smart inhalers' ability to gather and communicate data in real-time to healthcare practitioners about medicine usage, inhaler technique, and environmental variables. One digital therapeutics startup, Propeller Health, has created a sensor-based smart inhaler platform. The platform is made up of a sensor that fits onto common inhalers and monitors drug intake. The gathered information is transferred to a smartphone app, which gives patients and medical professionals information and alerts.

Restraints in the Global Smart Inhalers Market

The comparatively expensive price of smart inhalers in comparison to traditional inhalers is one of the market's limitations. Smart inhalers are more expensive because of their sophisticated technology and connection features. Their broad adoption may be constrained by their cost, especially in areas with scarce healthcare resources and affordability issues. For instance, the cost of a smart inhaler might vary from $100 to $300, based on the features and brand. Patients with low incomes or no insurance may find this increased expense to be problematic. Because of this, the market growth of smart inhalers may be hampered in some markets where their adoption is delayed.

Market Trends of the Global Smart Inhalers Market

The incorporation of machine learning (ML) and artificial intelligence (AI) algorithms into inhaler technology is a significant trend in the smart inhalers market. Large datasets gathered from smart inhalers can be analyzed by AI and ML approaches, which can also spot trends and offer predictive insights. This makes it possible for medical professionals to anticipate exacerbations, optimize medicine dosage, and customize treatment regimens. For instance, the digital health startup Cohero Health has created a smart inhaler system that uses ML and AI algorithms. In order to give patients and healthcare professionals individualized recommendations and real-time feedback, the system examines inhaler usage trends, environmental data, and patient-specific information. This trend demonstrates how AI and ML can be used to improve patient outcomes and the management of respiratory diseases.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Smart Inhalers Market by Type

• Market Overview
• Dry powdered inhalers (DPIs) and metered dose inhalers (MDIs)

Global Smart Inhalers Market by Distribution Channel

• Market Overview
• Hospital pharmacies
• retail pharmacies
• and online pharmacies

Global Smart Inhalers Market by End-Use

• Market Overview
• Hospitals
• homecare settings
• and others

Global Smart Inhalers Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Teva Pharmaceuticals (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Respironics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Propeller Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vectura Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Opko Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Adherium Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohero Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• H&T Presspart (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mundipharma (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glenmark Pharmaceuticals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chiesi Farmaceutici (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Propeller Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensirion AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments